2018 annual financial data
Outlook Therapeutics 2018 Operating margin
Outlook Therapeutics 2018 operating margin with verified reported values.
Direct answer
Operating margin was -959.97%.
Operating income was -29,644,000 USD and net income was -30,092,000 USD.
Operating cash flow was Not available.
Get free Outlook Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3,088,000 USD
- Operating income
- -29,644,000 USD
- Net income
- -30,092,000 USD
- Operating cash flow
- Not available